TheraCryf (FRA:8EV) Shares Buyback Ratio % : 0.00 (As of May. 21, 2024)

View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. TheraCryf's current shares buyback ratio was 0.00%.

TheraCryf Shares Buyback Ratio % Historical Data

The historical data trend for TheraCryf's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Shares Buyback Ratio % Chart

TheraCryf Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-6.13

-34.00

-104.21

TheraCryf Semi-Annual Data
	Mar13	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-	-	-

TheraCryf Shares Buyback Ratio % Calculation

TheraCryf's Shares Buyback Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Mar. 2022 )	-	Shares Outstanding (EOP) (A: Mar. 2023 ))	/	Shares Outstanding (EOP) (A: Mar. 2022 )
	=	(274.888	-	274.888)	/	274.888
	=	0.00%

TheraCryf's Shares Buyback Ratio for the quarter that ended in Sep. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Mar. 2023 )	-	Shares Outstanding (EOP) (A: Sep. 2023 ))	/	Shares Outstanding (EOP) (A: Mar. 2023 )
	=	(274.888	-	274.888)	/	274.888
	=	0.00%

TheraCryf Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of TheraCryf's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

TheraCryf (FRA:8EV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

EVG:UK

Address

Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG

Website

https://www.evgen.com

Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.

TheraCryf (FRA:8EV) Headlines

No Headlines